Clinical trial to evaluate experimental treatment in people allergic to multiple foods
NIH and partners to assess whether Omalizumab can reduce allergic reactions.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: Allergy & Immunology | American Health | Clinical Trials | National Institutes of Health (NIH) | Xolair